CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
43.30
-1.43 (-3.20%)
At close: Dec 5, 2025, 4:00 PM EST
43.67
+0.37 (0.85%)
After-hours: Dec 5, 2025, 6:24 PM EST

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4932,183---
Enterprise Value
2,8201,643---
Last Close Price
43.3028.68---
PS Ratio
1606.641916.94---
PB Ratio
4.932.98---
P/TBV Ratio
5.192.98---
EV/Sales Ratio
1297.071442.48---
Debt / Equity Ratio
0.0100.000.130.38
Asset Turnover
0.000.000.000.00-
Quick Ratio
22.3034.7613.179.328.97
Current Ratio
22.7935.3013.629.549.78
Return on Equity (ROE)
-24.74%-19.18%-31.36%-42.85%-
Return on Assets (ROA)
-17.56%-15.02%-19.97%-21.34%-
Return on Capital (ROIC)
-18.28%-15.60%-21.24%-22.42%-
Return on Capital Employed (ROCE)
-25.80%-15.60%-30.00%-26.60%-23.90%
Earnings Yield
-4.34%-4.03%---
FCF Yield
-3.35%-3.62%---
Buyback Yield / Dilution
-60.24%-1343.03%-15.77%-2.48%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q